ERIC 2018 Session IV
Looking to the Future in CLL Treatment
In session IV of ERIC 2018 meeting, Robin Foà, MD, and Peter Hillmen, MBChB, PhD, talk about real world evidence to guide therapy and the need to aim for MRD eradication in order to stop therapy and move to cure.
Presentations
Aiming at MRD Eradication: Why and How?
Peter Hillmen, MBChB, PhD
University of Leeds, Leeds, UK
University of Leeds, Leeds, UK
26 October, 2018
Peter Hillmen, MBChB, PhD, from the University of Leeds, Leeds, UK, discusses the importance of MRD eradication in CLL.
What does the Future Hold? Projections From Real Life Experience
Robin Foà, MD
Sapienza University of Rome, Rome, Italy
Sapienza University of Rome, Rome, Italy
26 October, 2018
Robin Foà, MD, of Sapienza University of Rome, Rome, Italy, talks about the future directions for CLL.
